<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02513433</url>
  </required_header>
  <id_info>
    <org_study_id>65/IEC/01/12-13</org_study_id>
    <nct_id>NCT02513433</nct_id>
  </id_info>
  <brief_title>Comparison of Levobupivacaine, Ropivacaine and Bupivacaine in Epidural Anaesthesia</brief_title>
  <official_title>Comparative Evaluation of Newer Congeners i.e. Levobupivacaine and Ropivacaine With Bupivacaine, in Lumbar Epidural Anaesthesia for Hip Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Government Medical College, Haldwani</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Government Medical College, Haldwani</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the clinical efficacy of newer local anaesthetic drugs Levobupivacaine
      and Ropivacaine with Bupivacaine in lumbar epidural anaesthesia for hip surgeries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Some of the most common day care surgeries are hip surgeries, in which local anaesthetic
      agents can be used via epidural route for both intra-op and post-op analgesia.

      Among the drugs used nowadays are Lignocaine, Bupivacaine, Levobupivacaine and
      Ropivacaine.However Bupivacaine usage is not free from side effects.

      The claimed benefits of both Levobupivacaine and Ropivacaine are reduced cardiac toxicity on
      overdose and more specific effects on sensory rather than motor nerve fibres.

      Ropivacaine, an analog of Mepivacaine, is one of the long acting amide anaesthetic agent
      similar to Bupivacaine in chemical structure and anaesthetic function. It is a first
      enantiomer-specific compound, which has a reduced risk of cardio toxicity, neuro toxicity and
      rapid recovery of motor function. Levobupivacaine is the pure S (âˆ’)-enantiomer of
      Bupivacaine, and in recent year has emerged as a safer alternative for regional anaesthesia
      than its racemic parent.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Onset of sensory block</measure>
    <time_frame>30 minutes</time_frame>
    <description>Time to achieve sensory block up to tenth thoracic dermatome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time for 2 segment regression of sensory block</measure>
    <time_frame>90 minutes</time_frame>
    <description>Time for regression of sensory block 2 segments lower than maximum blocked dermatome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to achieve maximum motor block</measure>
    <time_frame>45 minutes</time_frame>
    <description>Time to achieve motor block of modified Bromage score</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Pain Insensitivity, Congenital</condition>
  <arm_group>
    <arm_group_label>Bupivacaine &amp; Levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine 15 ml 0.5% and Levobupivacaine 15 ml 0.5% in epidural route before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine &amp; Ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine 15 ml 0.5% and Ropivacaine 15 ml 0.75% in epidural route before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine &amp; Levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ropivacaine 15 ml 0.75% and Levobupivacaine 15 ml 0.5% in epidural route before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Local anesthetic</description>
    <arm_group_label>Bupivacaine &amp; Levobupivacaine</arm_group_label>
    <arm_group_label>Bupivacaine &amp; Ropivacaine</arm_group_label>
    <other_name>Anawin</other_name>
    <other_name>Sensorcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <description>Local anesthetic</description>
    <arm_group_label>Bupivacaine &amp; Levobupivacaine</arm_group_label>
    <arm_group_label>Ropivacaine &amp; Levobupivacaine</arm_group_label>
    <other_name>Levo-anawin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Local anesthetic</description>
    <arm_group_label>Bupivacaine &amp; Ropivacaine</arm_group_label>
    <arm_group_label>Ropivacaine &amp; Levobupivacaine</arm_group_label>
    <other_name>Ropin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA Grade I and II patients of either sex

          -  Age 18-60 years

          -  Undergoing various hip surgeries under lumbar epidural anesthesia

        Exclusion Criteria:

          -  Refusal for epidural

          -  ASA-III&amp;IV

          -  Head injury

          -  Psychiatric disease

          -  Known allergic to test drugs

          -  Major systemic disease

          -  Any analgesia with in past 24 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Geeta Bhandari, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor and Head of the department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Government Medical College</name>
      <address>
        <city>Haldwani</city>
        <state>Uttarakhand</state>
        <zip>263139</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2015</study_first_submitted>
  <study_first_submitted_qc>July 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2015</study_first_posted>
  <last_update_submitted>July 31, 2015</last_update_submitted>
  <last_update_submitted_qc>July 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Government Medical College, Haldwani</investigator_affiliation>
    <investigator_full_name>Dr Subhro Mitra</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Lumbar epidural anaesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain Insensitivity, Congenital</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

